ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1

Clinical trial NCT00140595 · COMPLETED

Trial details

NCT number: NCT00140595
Sponsor: Lymphoma Study Association
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large-Cell Lymphoma

Start date: 2003-12-01
Primary completion: 2009-01-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.